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Abstract
Several studies have highlighted the therapeutic potential of transcranial direct current stimulation (tDCS) in
patients with neurological diseases, including dementia, epilepsy, post-stroke dysfunctions, movement disorders,
and other pathological conditions.
Because of this technique’s ability to modify cerebellar excitability without significant side effects, cerebellar tDCS is
a new, interesting, and powerful tool to induce plastic modifications in the cerebellum.
In this report, we review a number of interesting studies on the application of cerebellar tDCS for various
neurological conditions (ataxia, Parkinson’s disease, dystonia, essential tremor) and the possible mechanism by
which the stimulation acts on the cerebellum.
Study findings indicate that cerebellar tDCS is a promising therapeutic tool in treating several neurological
disorders; however, this method’s efficacy appears to be limited, given the current data.
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Background
The cerebellum is an interesting and fascinating part of
the central nervous system, which plays a fundamental
role in movement execution and motor control in
humans [1].
Beyond its role in balance and motor control, the hu-
man cerebellum has been extensively studied for its po-
tential roles in learning, cognition, emotions, and
behaviour [2, 3]. Indeed, experiments using neurotropic
viruses as transneuronal tracers have demonstrated that
the cerebellar output influences not only the primary
motor cortex but also the premotor, prefrontal, and
parietal areas [3].
The interaction between the cerebellum and the cere-
bral cortex is based on multiple closed-loop circuits,
which have been traditionally considered anatomically
and functionally distinct from the cerebro-basal ganglia
loops. However, recent anatomical experiments have
shown that the dentate nucleus projects disynaptically to
the striatum [4] and that the subthalamic nucleus of the
basal ganglia projects to the cerebellar cortex [5]. This
interconnection between the cerebellum and the basal
ganglia provides an explanation for the cerebellar in-
volvement in disorders that are commonly associated
with basal ganglia dysfunction (for example, Parkinson’s
disease (PD) and dystonia) [6, 7].
Recent findings concerning the anatomical and func-
tional connections between the cerebellum and the basal
ganglia may help to characterize the role of the cerebel-
lum in Parkinson’s disease [7]. The cerebellum was
shown to receive a dopaminergic projection from the
ventral tegmental area/substantia nigra pars compacta
[8–10] and to exhibit dopamine D1–3 receptors [11, 12].
Moreover, pathological changes in the cerebellum fol-
lowing dopaminergic degeneration have been reported
in patients with Parkinson’s disease and animal models
[13, 14]. Functional neuroimaging studies demonstrated
increased activation in the cerebellum in patients with
PD during motor execution [15–20], during the motor
learning process [21–23], as well as in the resting state
[24]. A PET study on trial-and-error sequence learning
determined that mildly affected patients with PD showed
a similar performance with respect to controls but acti-
vated four times as much neural tissue, including the
cerebellum [25]. It was suggested that the functional role
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of the increased activity or connectivity in the cerebello-
thalamo-cortical loop in PD could be to compensate for
hypofunction in the striato-thalamo-cortical circuit [7].
Indeed Yu and colleagues [20] observed a significant
negative correlation between the blood oxygen level–
dependent activation in the ipsilateral cerebellum and
the contralateral putamen while performing a right hand
pressing task.
There is strong evidence that the cerebellum also plays
an important role in dystonia [6, 26–30]. Recent studies
have shown subtle defects in cerebellar Purkinje cells in
autopsy specimens from patients with cervical dystonia
[31, 32]. Furthermore, imaging studies revealed that ab-
normalities in the basal ganglia frequently coexist with
abnormalities in the cerebellum [33–37]. These data
suggest that cerebellum function is incompletely charac-
terized and is probably more expansive than expected.
Because of the multiple cerebellar connections and the
broad variety of motor and non-motor functions, the
field of cerebellar stimulation with non-invasive tech-
niques (particularly transcranial magnetic stimulation
(TMS) and transcranial direct current stimulation
(tDCS)) is enjoying great success among scientists in the
last several years. These techniques enable researchers
to investigate neural networks non-invasively and enable
them to obtain more information regarding cerebellar
physiology and to promote neural plasticity [38].
In 1995, Ugawa [39] found that a single magnetic cere-
bellar pulse inhibited the amplitude of the motor evoked
potential, evoked by TMS delivered a few milliseconds
later over the contralateral motor cortex [39, 40]. This
inhibition was mediated through the pathway between
the cerebellum and the primary motor cortex and was
termed cerebellar brain inhibition (CBI).
Controversial results were observed regarding the ef-
fects of tDCS on CBI. Galea and colleagues [41] found
that anodal tDCS induced an increase of CBI, suggesting
that it could act by stimulating tonic Purkinje cell activ-
ity, thereby potentiating the inhibitory effect of the
dentato-thalamo-cortical pathway on the motor cortex.
Nevertheless, Doeltgen and colleagues [42] found that
anodal tDCS resulted in a reduction of CBI, suggesting
that instead of Purkinje cells, anodal tDCS could modu-
late superficially located inhibitory interneurons project-
ing to them, or alternatively, cerebello-thalamo-cortical
projections could target inhibitory interneurons within
the primary motor cortex. Because of its ability to mod-
ify cerebellar excitability without significant side effects,
cerebellar tDCS is a new, interesting, and powerful tool
to induce plastic modifications in the cerebellum.
In this report, we review a number of interesting stud-
ies regarding the application of cerebellar tDCS for dif-
ferent neurological conditions (Table 1) and the possible
mechanism by which the stimulation acts on the
cerebellum. Cerebellar tDCS has been applied not only
to patients affected by primary degenerative cerebellar
disorders (e.g., cerebellar ataxias) but also to patients af-
fected by disorders that primarily affect the basal ganglia
(e.g., PD, dystonia). Therefore, by modulating cerebellar
excitability, cerebellar tDCS could potentially represent a
promising therapeutic strategy for movement disorders.
Cerebellar tDCS studies
Evidence from clinical studies suggests that the cerebel-
lum may be involved in the pathophysiology of move-
ment disorders, such as dystonia [6], essential tremor
[43], PD [44] and cerebellar ataxia [45], and may be a
useful target for tDCS intervention [38, 46].
Parkinson’s disease
Levodopa-induced dyskinesias (LIDs) most likely arise
through the cerebello-thalamo-cortical circuit. To evalu-
ate how cerebellar tDCS affects LIDs and cognitive func-
tion in PD, Ferrucci and colleagues [47] delivered
bilateral anodal (cerebellar tDCS or M1-tDCS) and sham
tDCS. After patients received anodal cerebellar tDCS
and M1-tDCS for 5 days, the UPDRS IV score (dyskine-
sias section) improved; conversely, the other variables
were unchanged after sham tDCS, cerebellar tDCS, and
M1-tDCS.
Despite the small sample size, these preliminary results
show that anodal tDCS applied for five consecutive days
over the motor cortical areas and the cerebellum im-
proves the LIDs of patients with PD. This finding pro-
vides the first evidence that cerebellar tDCS affects
LIDs, thus corroborating and extending our current
knowledge on the role of the cerebellum in the patho-
physiology of PD [7]. Important limitations of this study
are the lack of a pharmacological correlation analysis, no
inclusion of healthy subjects, and the demonstration that
administering L-dopa turns facilitation caused by anodal
tDCS into inhibition and prolongs the inhibitory effects
of cathodal tDCS.
Dystonia
To investigate the role of the cerebellum in dystonia,
Bradnam and colleagues [48] evaluated whether cerebel-
lar tDCS improves handwriting and cyclic drawing kine-
matics by reducing CBI evoked by TMS in patients with
writing dystonia. These researchers examined the kine-
matic measures, mean stroke frequency with handwrit-
ing and fast cyclic drawing, and average pen pressure
during light cyclic drawing at baseline in patients and a
control group. They examined these measurements after
anodal, cathodal, and sham tDCS. The results showed
that cerebellar anodal tDCS reduced handwriting mean
stroke frequency and average pen pressure, and in-
creased speed and reduced pen pressure during fast
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Table 1 Cerebellar Transcranial Direct Current Stimulation (tDCS) studies
Author &
year
Sample Trial type Polarity
and
number
of
sessions
Stimulation
electrode
position
Reference
electrode
position
Current
strength
and
duration
Outcome Online/
Offline
procedure
Follow-
up
Results
Parkinson’s disease
Ferrucci
et al.
(2015)
[47]
N = 9 (74.3 ± 8) Randomized,
double blind,
cross-over
A/S 5
daily
tDCS
Whole
cerebellum
or bilateral
M1
Right deltoid
muscle
2 mA,
20 min
UPDRS (III-IV),
PDQ8, BDI, word
recall, spatial
cueing, SRTT
Offline 1–4
week
A tDCS over M1 and cerebellum improved:
UPDRS(dyskinesia section) score by about
20 %.
Dystonia
Sadnicka
et al.
(2014)
[50]
N = 10 (not reported) Randomized,
double-blind
A/S
single
tDCS
Right
cerebellar
cortex
Right
buccinator
muscle
2 mA,
15 min
RMT, AMT, RC,
CSP, VAS
Offline No Negative
Bradnam
et al.
(2015)
[48]
N = 16 8 patients (59 ± 13) 8
healthy subjects (61.21 ± 11.73)
Randomized,
double-blind
A/C/S
single
tDCS
Right
cerebellar
cortex
Right
buccinator
muscle
2 mA,
20 min
ADDS, WCRS,
MEPs, MFS, APP
Offline No A tCDCS improved: APP by 12.81 %. A-C
tDCS reduced handwriting MSF (A: 8.47 %;
C: 9.6 %).
Essential Tremor
Gironell
et al.
(2014)
[51]
N = 10 (71.4 not reported) Randomized,
double blind,
cross-over
C/S
5daily
tDCS
Bilateral
cerebellar
cortex
Fp 1, Fp2 2 mA,
20 min
TCRS,
accelometric
recording, self-
reporteddisability
scale
Offline 4 weeks Negative
Cerebellar Ataxia
Grimaldi
et al.
(2013)
[52]
N = 9 (mean age 51.3 ± 14) Single blind,
sham-
controlled
A/S Right
cerebellar
cortex,
vermis
Contralateral
supra-orbital
area
1 mA,
20 min
SR, MCT,
Computerized
Posturography
Offline No A tCDCS reduced the amplitudes of long-
latency stretch reflexes
Grimaldi
et al.
(2014)
[53]
N = 2 (mean age 46 ± 4.24) Single blind,
sham-
controlled
A/S Right
cerebellar
cortex, Left
M1
Contralateral
supra-orbital
area, right
supra-orbital
area
1 mA,
20 +
20 min
SARA, Upper limb
tremor (postural
and action
tremor),
dysmetria
Offline No A tCCDCS reduced: the PSD peak by 38.63
and 41.42 % in both patients, the
magnitude of low frequency oscillations by
46.9 and 62.3 % respectively, and the onset
latency of the hypermetria by about 41 and
45 %.
Benussi
et al.
(2015)
[54]
N = 19 (mean age 53.8 ± 18.4) Randomized,
double blind,
cross-over;
sham-
controlled
A/S Cerebellar
cortex
Right deltoid
muscle
2 mA
20 min
SARA, ICARS,
9HPT, 8 MW
offline No A tCDCS improved: SARA by about 10 %,
ICARS by 12 %, 9HPT by 11 %, 8 MW by
11 %.
A anodal tDCS, ADDS arm dystonia disability scale, AMT active motor threshold, APP average pen pressure, BDI beck depression inventory, C cathodal tDCS, ICARS International Cooperative Ataxia Rating Scale, M1
motor cortex, mA milliampere, MCT Mechanical Counter Test, Min minutes, MEPs motor evoked potentials, MSF mean stroke frequency, Offline the subject receives stimulation before and after executing the task,
Online the subject receives stimulation during the task, PDQ-8 Parkinson’s disease questionnaire 8, Fp prefrontal areas, PSD power spectral density, S sham tDCS, SARA scale for the Assessment and Rating of Ataxia, SR
Stretch reflexes, SRTT serial reaction time task, tCDCS transcranial cerebellar direct current stimulation, tCCDCS transcranial cerebello-cerebral direct current stimulation, tDCS transcranial direct current stimulation, TCRS
tremor clinical rating scale, UPDRS Unified Parkinson’s disease rating scale, VAS visual analog scale, WCRS writer’s cramp rating scale, 9HPT Nine-Hole Peg Test, 8MW 8-Meter Walking Time
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cyclic drawing. Kinematic measures were not associated
with a decrease in CBI.
Primary dystonia is characterized neurophysiologically
by reduced inhibitory mechanisms and an abnormal
regulation of plasticity responses. The method com-
monly used to induce LTP-like (long-term potentiation)
plasticity is paired associative stimulation (PAS). This
protocol induces plastic changes in excitability in the hu-
man motor cortex [49]. In their study, Sadnicka and col-
leagues [50] used cerebellar tDCS to examine the
electrophysiological parameters (resting and active
motor threshold, motor cortex excitability, recruitment
curves, and cortical silent period) in ten patients with
writing dystonia. Patients completed a two-session study
(sham and anodal) in which the cerebellum was stimu-
lated along with simultaneous application of PAS.
Patients were also clinically evaluated with the writing
movement subscore of the Writer’s Cramp Rating Scale
and with a self reported visual analog scale.
The results were negative and do not provide evidence
that anodal cerebellar tDCS is beneficial for patients
after a single session.
Based on these limited and contradictory results, we
conclude that the evidence supporting cerebellar tDCS,
as a clinically viable method for treating dystonia is un-
convincing. To the best of our knowledge, no one has
investigated the effects of consecutive cerebellar tDCS
sessions or the effects of combining it with motor train-
ing. Further research is needed to investigate ways for
increasing the magnitude of the cerebellar tDCS effect.
Essential tremor
Essential tremor (ET) is a common neurological disorder
that is characterized by action tremor, which affects the
upper limbs in at least 95 % of patients. Tremor is asso-
ciated with a dysfunction in the basal ganglia and the
cerebellar circuit, as well as several neurotransmitter sys-
tems projecting to both of these circuits. In a random-
ized, controlled and crossover study, Gironell and
colleagues [51] evaluated the efficacy and safety of ten
consecutive cerebellar tDCS sessions in patients with
ET. Participants performed a tremor clinical rating scale
(TCRS), a test that measures motor performance, daily
living activities, or the patients’ subjective assessment,
accelerometric recordings and a self-reported disability
scale after receiving cathodal stimulation over both cere-
bellar hemispheres. The authors found no significant dif-
ferences in the way tDCS affects outcome measures
between baseline, day 10 and day 40 (30 days after the
last tDCS session).
Although they investigated both the acute and long-
lasting effects of tDCS, this small and preliminary study
yielded negative results. It is not clear how the four
tDCS electrodes were applied over the scalp. The
authors have reported two cathodal electrodes placed
symmetrically over both cerebellar hemispheres and two
anodal electrodes over both prefrontal areas, without
specifying if they were unilateral or cross montage.
Moreover, it is questionable whether a discomfort ques-
tionnaire was administered along with the tDCS proced-
ure and if the subjects were successfully blinded with
2 mA tDCS to the stimulation conditions. It would have
been informative if the subjects had been asked if they
received real or sham stimulation.
Given the ample evidence in the literature supporting
the ability of cerebellar tDCS to enhance motor and
non-motor function, the prospect of further trials for
neurological disorders is encouraging.
Cerebellar ataxia
Another recent study has investigated the role of tDCS
to modulate the activity of the cerebellum in ataxic dis-
orders and has reported interesting results.
To evaluate the effects of anodal tDCS on the cerebel-
lum, Grimaldi and colleagues [52] conducted a study
with nine ataxic patients. The authors studied the
stretch reflexes (SR) in the upper limbs and examined
upper limb dexterity and coordination using a mechan-
ical counter test (MCT). These researchers also used a
computerized posturograph during three experimental
paradigms. Their results showed that anodal tDCS
(1 mA, 20 min) over the right cerebellar hemisphere re-
duced the amplitude of the long latency SR (LLSR) re-
sponse, but did not affect the short latency SR response
or the MCT score compared to the baseline and sham
group. Additionally, the postural parameters remained
unchanged following sham or active stimulation of the
region in front of the vermis.
These data collectively demonstrated that anodal tDCS
applied over the cerebellum reinforces the inhibitory ac-
tivity exerted by the cerebellar cortex over cerebellar nu-
clei. tDCS of the cerebellum appears to be a novel
method to study the modulation of LLSR by the cerebel-
lar cortex.
In a subsequent study, the same authors [53] per-
formed tDCS over the cerebellum for 20 min immedi-
ately followed by tDCS applied over the contralateral
motor cortex (20 min, 1 mA) (tCCDCS: transcranial
cerebello-cerebral DC stimulation) to assess upper limb
tremor and dysmetria in two patients with dominant spi-
nocerebellar ataxia. They found that for the postural
tremor, tCCDCS induced a reduction in the amplitude
of the oscillations at the level of the index in both pa-
tients, as reported by quadratic power spectral density
(PSD). tCCDCS also had a positive effect on action
tremors, as observed by the drop in the magnitude of
low-frequency oscillations from 62.3 to 46.9 % of the
baseline values in patient 1 and 2, respectively.
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Remarkably, following tCCDCS, hypermetria occurred
along with a reduction of the onset latency of the antag-
onist EMG activity in both patients.
Despite the small sample and the lack of follow-up
precluding the investigators from assessing how long the
effect lasted, these results are highly encouraging. The
combination of tDCS of the cerebellum with tDCS of
the motor/premotor cortex demonstrated that this tech-
nique may be considered a symptomatic therapeutic
strategy for upper limb deficits in disabling cerebellar
ataxia, representing a novel approach in the field of cere-
bellar neuromodulation.
An interesting therapeutic effect was also observed by
Benussi and colleagues [54]. In a double-blind, random-
ized, sham-controlled study, they investigated whether a
single session of cerebellar anodal transcranial direct
current stimulation could improve symptoms in nine pa-
tients with ataxia. Each patient received both anodal and
sham cerebellar tDCS stimulation (20 min, 2 mA) in two
different sessions, separated by at least 1 week.
After cerebellar tDCS, there was a significant improve-
ment in the functional clinical scores, as observed with
the Scale for the Assessment and Rating of Ataxia
(SARA), the International Cooperative Ataxia Rating
Scale (ICARS), and in motor task measurement with the
nine-hole peg test (9HPT) and 8-Meter Walking Time
(8 MW) assessment within the entire cohort of patients.
Specifically, the individual assessments of the four sub-
scores on the ICARS scale revealed a significant im-
provement in the posture, gait and limb coordination
subscores. Moreover, single-group analysis in the SCA
(spinocerebellar ataxia) and the cerebellar variant of
MSA (multiple system atrophy, MSA-C) cohorts demon-
strated a significant effect from anodal cerebellar tDCS
on SARA, ICARS, and 9HPT testing. Only in the SCA
group was there a significant difference in the 8MW
testing. There was no significant difference in the MSA-
C group.
The investigators concluded that a single stimulation
session applied to the cerebellar cortex can temporarily
improve symptoms in patients with ataxia and might
have therapeutic potential in these patients, but more
powerful stimulation may be needed.
These preliminarily studies show that cerebellar tDCS is
safe and can improve neurological symptoms, especially in
patients with ataxia. While this finding is promising, the
clinical efficacy of this technique in patients with neuro-
logical disorders remains to be definitively established by
large, controlled clinical studies. Future research efforts
should be directed toward identifying the optimal stimula-
tion parameters (electrode montage and size, duration, in-
tensity, number of sessions, on-line vs. off-line, duration
of treatment), and potentially targeting specific types of
neurological disorders or individual patients.
Mechanisms of action
Two main questions concerning the mechanism of
action of cerebellar tDCS are still unanswered: 1)
whether cerebellar tDCS has polarity-specific effects
or not and 2) whether it modulates cerebellar activ-
ity during or following a behavioural intervention
(on-line versus off-line effects).
Differences in the reported effects are mainly due to
the function explored, as different functions rely on dif-
ferent cerebellar areas with variable neural substrates
and axonal orientation to the electrical field. Some au-
thors have reported polarity-specific effects [41, 55–57],
while others have not [58, 59]. This apparent discrep-
ancy may be due to differences in the electrode size and
the montage, as well as variations in the stimulation
intensity [60]. In particular, while studies exploring
cognitive and emotional domains have used a classical
monopolar configuration, others focusing on motor
functions have adopted a different montage, in which
the return electrode is placed over the ipsilateral face.
Only in the last study montage have polarity-specific ef-
fects been demonstrated [41].
Cerebellar tDCS probably has both on-line and off-
line effects on cerebellar excitability. This finding would
be in concordance with the effects elicited by tDCS in
the cerebral cortex that are observable after both short-
term and long-term delays and most likely interfering
with long-term potentiation (LTP-like) phenomena [61].
From a cellular point of view, animal studies seem to
suggest that the electrical stimulation of Purkinje cells
mediates on-line effects [62], whereas depolarization of
Golgi inhibitory neurons is responsible for long-lasting
changes [63]. Purkinje cells represent the sole output
from the cerebellar cortex, and their activation leads to
the inhibition of the dentate nucleus, ultimately damp-
ening motor cortex excitability, a phenomenon referred
to as CBI [40]. Cerebellar tDCS may interfere with this
connectivity, depending on its polarity and intensity.
Nonetheless, electrical fields induced by cerebellar tDCS
in humans are much smaller than those used in animals,
thus making it difficult to compare their mechanisms of
action [64, 65].
From a molecular perspective, cerebellar polarization
may act on different neurotransmitters and signalling
pathways [66]. For instance, the two main neurotrans-
mitters in the cerebellum (glutamate and γ-amino-
butyric acid) are both modulated when tDCS is applied
over the sensorimotor areas [66]. In addition, the con-
centration of cerebellar myo-inositol is likely modified
by weak electrical fields, as is the case for transcranial
current stimulation [67]. Finally, cerebellar tDCS may
interfere with dopaminergic transmission, probably
through disynaptic pathways leading from the cerebel-
lum to the intralaminar nuclei of the thalamus and to
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the dorsolateral putamen [4]. The cerebellum itself
expresses all types of dopamine receptors that share
similar properties with the striatal dopaminergic sys-
tem [68]. The cerebellum also down-regulates the
striatal D1 receptors through the deep nuclei and the
thalamic relay [11].
As a whole, anodal and cathodal cerebellar tDCS likely
exert effects through different, rather than simply specu-
lar, mechanisms of action on different cellular and mo-
lecular targets, in concordance with those reported both
for the cerebral cortex [66] and spinal cord [56]. The po-
larity of cerebellar tDCS after-effects may also depend
on the pre-existing excitability state, as well as with task-
induced activity, as described for cortical stimulation
[69]. Elucidation of the physiological variables under-
lying tDCS after-effects and evidence for the existence of
a cerebellar homeostatic-like plasticity would be critical
areas to investigate extensively in future studies.
Conclusions
Cerebellar tDCS is a novel, safe and effective neurosti-
mulation technique for non-invasive modulation of cere-
bellar excitability. Depending of the different
pathophysiologies of human diseases, it has been suc-
cessfully used for the treatment of movement disorders,
ranging from cerebellar ataxia to dystonia, as well as for
the control of levodopa-induced dyskinesias in Parkin-
son’s disease patients. Modelling studies have demon-
strated that the cerebellum is the structure mainly
affected by cerebellar tDCS, without a significant current
spreading to the brainstem or the occipital cortex.
Studies on healthy subjects have demonstrated that
cerebellar tDCS influences the pain experience, nocicep-
tive perception [55, 56], and cognitive function [46].
However, further studies are needed to elucidate this
technique’s mechanisms of action and areas of influence.
Moreover, it is worth remembering that cerebellar in-
volvement in non-motor (i.e., cognitive) functions re-
mains to be systematically evaluated.
Despite the wide heterogeneity of the limited data
available for review, we will try to offer some practical
operative suggestions for those wishing to approach
cerebellar tDCS to treat patients with neurological
disease.
First, whereas anodal tDCS improves motor functions
over the right cerebellum, cathodal cerebellar tDCS
seems to be ineffective. The second suggestion concerns
stimulation duration and intensity. The optimal repeti-
tion rate and duration to promote tDCS-induced plasti-
city remains undetermined.
A reasonable choice might be 2 mA for 20 min, using
a common electrode size of 35 cm2 (generating charge
densities ranging from 0.034 to 0.068 C/cm2) in repeated
daily sessions (5 days). For instance, given that a recent
study of major depression concluded that treatment
should continue for several weeks or should combine
stimulation of the cerebellum and cerebral cortex to
achieve an optimal clinical response, the same might
apply to neurologic patients. At present, because most of
the available data on cerebellar tDCS-induced motor im-
provement concerns patients with ataxia, these patients
appear to be the most likely to respond positively.
Further research efforts should aim to identify the opti-
mal stimulation parameters (site, electrode montage and
size, duration, intensity, number of sessions, online vs. off-
line, duration of treatment), potentially targeting specific
types of neurological disease and individual patients.
Although current findings indicate that cerebellar
tDCS may be a promising therapeutic tool for treating
several neurological disorders, its efficacy appears lim-
ited and awaits further substantiation in large, rando-
mised controlled clinical studies.
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